Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical business.
Related Posts
Frontier’s Second Biggest Investor Opposes Sale to Verizon
Frontier Communications’ second largest investor is the latest stakeholder to come out against the company’s proposed $9.6 billion acquisition by Verizon Communications.
Wall Street Banks Prepare to Sell Billions of Dollars of X Loans
- staff
- January 24, 2025
- 0
Banks are hoping to sell the X debt at around 90 to 95 cents on the dollar.
Auto & Transport Roundup: Market Talk
Find insight on XPeng, Capital A and more in the latest Market Talks covering the Auto and Transport sector.